Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Weekly Administration of (bi-)Daily Oral Docetaxel in Combination With Ritonavir in Patients With Normal or Impaired Liver Function

NCT05084456 is registered in ClinicalTrials.gov with Modra Pharmaceuticals as lead sponsor.

NCT NCT05084456
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05084456 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Weekly Administration of (bi-)Daily Oral Docetaxel in Combination With Ritonavir in Patients With Normal or Impaired Liver Function
Lead sponsor
Modra Pharmaceuticals
Phase
Phase 1
Overall status
Withdrawn
Start date
July 31, 2017
Completion date
April 30, 2020
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

impaired liver function, solid tumor, adult